Transocean Ltd. (RIG)

ShockWave Medical Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	3,794	3,524	2,832	2,575	2,556	3,152
Revenue	3,794	3,524	2,832	2,575	2,556	3,152
Revenue Growth (YoY)	23.26%	24.44%	9.98%	0.74%	-18.91%	2.07%
Cost of Revenue	2,334	2,174	1,960	1,668	1,685	1,978
Gross Profit	1,460	1,350	872	907	871	1,174
Selling, General & Admin	204	216	192	180	161	209
Operating Expenses	925	955	936	915	903	990
Operating Income	535	395	-64	-8	-32	184
Interest Expense	-399	-362	-646	-561	-447	-575
Interest & Investment Income	39	50	52	27	15	21
Currency Exchange Gain (Loss)	16	16	10	-8	-1	-8
Other Non Operating Income (Expenses)	-40	7	-3	14	43	44
EBT Excluding Unusual Items	151	106	-651	-536	-422	-334
Gain (Loss) on Sale of Investments	-1	-1	-19	-24	-37	-59
Gain (Loss) on Sale of Assets	-2	-17	-183	-10	-62	-84
Asset Writedown	-1,765	-772	-57	-	-	-597
Other Unusual Items	21	161	-31	8	51	533
Pretax Income	-1,596	-523	-941	-562	-470	-541
Income Tax Expense	-92	-11	13	59	121	27
Earnings From Continuing Operations	-1,504	-512	-954	-621	-591	-568
Net Income to Company	-1,504	-512	-954	-621	-591	-568
Minority Interest in Earnings	-	-	-	-	-1	1
Net Income	-1,504	-512	-954	-621	-592	-567
Net Income to Common	-1,504	-512	-954	-621	-592	-567
Shares Outstanding (Basic)	882	850	768	699	637	615
Shares Outstanding (Diluted)	882	925	768	699	637	615
Shares Change (YoY)	9.43%	20.44%	9.87%	9.73%	3.58%	0.49%
EPS (Basic)	-1.71	-0.60	-1.24	-0.89	-0.93	-0.92
EPS (Diluted)	-1.92	-0.76	-1.24	-0.89	-0.93	-0.92
Free Cash Flow	383	193	-263	-269	367	133
Free Cash Flow Per Share	0.43	0.21	-0.34	-0.39	0.58	0.22
Gross Margin	38.48%	38.31%	30.79%	35.22%	34.08%	37.25%
Operating Margin	14.10%	11.21%	-2.26%	-0.31%	-1.25%	5.84%
Profit Margin	-39.64%	-14.53%	-33.69%	-24.12%	-23.16%	-17.99%
Free Cash Flow Margin	10.10%	5.48%	-9.29%	-10.45%	14.36%	4.22%
EBITDA	1,256	1,138	732	844	930	1,180
EBITDA Margin	33.11%	32.29%	25.85%	32.78%	36.38%	37.44%
D&A For EBITDA	721	743	796	852	962	996
EBIT	535	395	-64	-8	-32	184
EBIT Margin	14.10%	11.21%	-2.26%	-0.31%	-1.25%	5.84%

Updated Aug 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q